Reimbursement Trends and Evidence Requirements for Ultra-Orphan Therapies Across Europe- Optimising Market Access in Increasingly Challenging Markets

Nov 1, 2014, 00:00
10.1016/j.jval.2014.08.1097
https://www.valueinhealthjournal.com/article/S1098-3015(14)03027-7/fulltext
Title : Reimbursement Trends and Evidence Requirements for Ultra-Orphan Therapies Across Europe- Optimising Market Access in Increasingly Challenging Markets
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(14)03027-7&doi=10.1016/j.jval.2014.08.1097
First page : A431
Section Title : Health Care Use and Policy Studies
Open access? : No
Section Order : 599
Categories :
Tags :
Regions :
ViH Article Tags :